371 related articles for article (PubMed ID: 29017096)
1. Enhancing miR-132 expression by aryl hydrocarbon receptor attenuates tumorigenesis associated with chronic colitis.
Alzahrani AM; Hanieh H; Ibrahim HM; Mohafez O; Shehata T; Bani Ismail M; Alfwuaires M
Int Immunopharmacol; 2017 Nov; 52():342-351. PubMed ID: 29017096
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-132 suppresses autoimmune encephalomyelitis by inducing cholinergic anti-inflammation: a new Ahr-based exploration.
Hanieh H; Alzahrani A
Eur J Immunol; 2013 Oct; 43(10):2771-82. PubMed ID: 23780851
[TBL] [Abstract][Full Text] [Related]
3. Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4.
Hanieh H
Mol Cancer; 2015 Sep; 14():172. PubMed ID: 26377202
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice.
Polytarchou C; Hommes DW; Palumbo T; Hatziapostolou M; Koutsioumpa M; Koukos G; van der Meulen-de Jong AE; Oikonomopoulos A; van Deen WK; Vorvis C; Serebrennikova OB; Birli E; Choi J; Chang L; Anton PA; Tsichlis PN; Pothoulakis C; Verspaget HW; Iliopoulos D
Gastroenterology; 2015 Oct; 149(4):981-92.e11. PubMed ID: 26055138
[TBL] [Abstract][Full Text] [Related]
5. The aryl hydrocarbon receptor/microRNA-212/132 axis in T cells regulates IL-10 production to maintain intestinal homeostasis.
Chinen I; Nakahama T; Kimura A; Nguyen NT; Takemori H; Kumagai A; Kayama H; Takeda K; Lee S; Hanieh H; Ripley B; Millrine D; Dubey PK; Nyati KK; Fujii-Kuriyama Y; Chowdhury K; Kishimoto T
Int Immunol; 2015 Aug; 27(8):405-15. PubMed ID: 25862525
[TBL] [Abstract][Full Text] [Related]
6. Activation of the aryl hydrocarbon receptor pathway may ameliorate dextran sodium sulfate-induced colitis in mice.
Takamura T; Harama D; Matsuoka S; Shimokawa N; Nakamura Y; Okumura K; Ogawa H; Kitamura M; Nakao A
Immunol Cell Biol; 2010 Aug; 88(6):685-9. PubMed ID: 20231854
[TBL] [Abstract][Full Text] [Related]
7. Extract of Ilex rotunda Thunb alleviates experimental colitis-associated cancer via suppressing inflammation-induced miR-31-5p/YAP overexpression.
Chen G; Han Y; Feng Y; Wang A; Li X; Deng S; Zhang L; Xiao J; Li Y; Li N
Phytomedicine; 2019 Sep; 62():152941. PubMed ID: 31100679
[TBL] [Abstract][Full Text] [Related]
8. Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis.
Singh NP; Singh UP; Singh B; Price RL; Nagarkatti M; Nagarkatti PS
PLoS One; 2011; 6(8):e23522. PubMed ID: 21858153
[TBL] [Abstract][Full Text] [Related]
9. miR-370-3p Alleviates Ulcerative Colitis-Related Colorectal Cancer in Mice Through Inhibiting the Inflammatory Response and Epithelial-Mesenchymal Transition.
Lin L; Wang D; Qu S; Zhao H; Lin Y
Drug Des Devel Ther; 2020; 14():1127-1141. PubMed ID: 32214798
[TBL] [Abstract][Full Text] [Related]
10. Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis.
Bian Z; Li L; Cui J; Zhang H; Liu Y; Zhang CY; Zen K
J Pathol; 2011 Dec; 225(4):544-53. PubMed ID: 21590770
[TBL] [Abstract][Full Text] [Related]
11. Suppression of miR-21 and miR-155 of macrophage by cinnamaldehyde ameliorates ulcerative colitis.
Qu S; Shen Y; Wang M; Wang X; Yang Y
Int Immunopharmacol; 2019 Feb; 67():22-34. PubMed ID: 30530166
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory natural product goniothalamin reduces colitis-associated and sporadic colorectal tumorigenesis.
Vendramini-Costa DB; Francescone R; Posocco D; Hou V; Dmitrieva O; Hensley H; de Carvalho JE; Pilli RA; Grivennikov SI
Carcinogenesis; 2017 Jan; 38(1):51-63. PubMed ID: 27797827
[TBL] [Abstract][Full Text] [Related]
13. [Changes of expression of miR-155 in colitis-associated colonic carcinogenesis].
Li W; Han W; Zhao X; Wang H
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):257-62. PubMed ID: 24989910
[TBL] [Abstract][Full Text] [Related]
14. Nicotine suppresses acute colitis and colonic tumorigenesis associated with chronic colitis in mice.
Hayashi S; Hamada T; Zaidi SF; Oshiro M; Lee J; Yamamoto T; Ishii Y; Sasahara M; Kadowaki M
Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(10):G968-78. PubMed ID: 25258409
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-206 is involved in the pathogenesis of ulcerative colitis via regulation of adenosine A3 receptor.
Wu W; He Y; Feng X; Ye S; Wang H; Tan W; Yu C; Hu J; Zheng R; Zhou Y
Oncotarget; 2017 Jan; 8(1):705-721. PubMed ID: 27893428
[TBL] [Abstract][Full Text] [Related]
16. MiR-597-5p inhibits carcinogenesis and macrophage recruitment in colitis-related colorectal cancer via reducing the expression of CXCL5.
Li S; Yu M; Wang X; Fei B
Cancer Biol Ther; 2023 Dec; 24(1):2274122. PubMed ID: 37942533
[TBL] [Abstract][Full Text] [Related]
17. Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3.
Do EJ; Hwang SW; Kim SY; Ryu YM; Cho EA; Chung EJ; Park S; Lee HJ; Byeon JS; Ye BD; Yang DH; Park SH; Yang SK; Kim JH; Myung SJ
J Gastroenterol Hepatol; 2016 Aug; 31(8):1453-61. PubMed ID: 26711554
[TBL] [Abstract][Full Text] [Related]
18. Saccharomyces boulardii alleviates ulcerative colitis carcinogenesis in mice by reducing TNF-α and IL-6 levels and functions and by rebalancing intestinal microbiota.
Wang C; Li W; Wang H; Ma Y; Zhao X; Zhang X; Yang H; Qian J; Li J
BMC Microbiol; 2019 Nov; 19(1):246. PubMed ID: 31694526
[TBL] [Abstract][Full Text] [Related]
19. Suppression of microRNA-222-3p ameliorates ulcerative colitis and colitis-associated colorectal cancer to protect against oxidative stress
Wang XJ; Zhang D; Yang YT; Li XY; Li HN; Zhang XP; Long JY; Lu YQ; Liu L; Yang G; Liu J; Hong J; Wu HG; Ma XP
Front Immunol; 2023; 14():1089809. PubMed ID: 36776858
[TBL] [Abstract][Full Text] [Related]
20. Indigo Naturalis ameliorates murine dextran sodium sulfate-induced colitis via aryl hydrocarbon receptor activation.
Kawai S; Iijima H; Shinzaki S; Hiyama S; Yamaguchi T; Araki M; Iwatani S; Shiraishi E; Mukai A; Inoue T; Hayashi Y; Tsujii M; Motooka D; Nakamura S; Iida T; Takehara T
J Gastroenterol; 2017 Aug; 52(8):904-919. PubMed ID: 27900483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
